IGM Biosciences Inc. (IGMS) Tops Q4 EPS by 34c

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q4 EPS of ($1.19), $0.34 better than the analyst estimate of ($1.53). Revenue for the quarter came in at $372 thousand versus the consensus estimate of $304.78 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
• RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)